These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36152835)
1. Contribution of common plastic-related endocrine disruptors to epithelial-mesenchymal transition (EMT) and tumor progression. Pesonen M; Vähäkangas K Chemosphere; 2022 Dec; 309(Pt 1):136560. PubMed ID: 36152835 [TBL] [Abstract][Full Text] [Related]
2. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process. Lee HM; Hwang KA; Choi KC Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023 [TBL] [Abstract][Full Text] [Related]
3. Epithelial-Mesenchymal Transition: A Special Focus on Phthalates and Bisphenol A. Oral D; Erkekoglu P; Kocer-Gumusel B; Chao MW J Environ Pathol Toxicol Oncol; 2016; 35(1):43-58. PubMed ID: 27279583 [TBL] [Abstract][Full Text] [Related]
4. Cell junctions in the prostate: an overview about the effects of Endocrine Disrupting Chemicals (EDCS) in different experimental models. Scarano WR; Pinho CF; Pissinatti L; Gonçalves BF; Mendes LO; Campos SGP Reprod Toxicol; 2018 Oct; 81():147-154. PubMed ID: 30086341 [TBL] [Abstract][Full Text] [Related]
5. Bisphenol A and nonylphenol have the potential to stimulate the migration of ovarian cancer cells by inducing epithelial-mesenchymal transition via an estrogen receptor dependent pathway. Kim YS; Hwang KA; Hyun SH; Nam KH; Lee CK; Choi KC Chem Res Toxicol; 2015 Apr; 28(4):662-71. PubMed ID: 25690688 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer. Lee GA; Hwang KA; Choi KC Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962 [TBL] [Abstract][Full Text] [Related]
7. Role of Epithelial-Mesenchymal Transition in Tumor Progression. Gloushankova NA; Zhitnyak IY; Rubtsova SN Biochemistry (Mosc); 2018 Dec; 83(12):1469-1476. PubMed ID: 30878022 [TBL] [Abstract][Full Text] [Related]
8. Migration of endocrine-disrupting chemicals into food from plastic packaging materials: an overview of chemical risk assessment, techniques to monitor migration, and international regulations. Ong HT; Samsudin H; Soto-Valdez H Crit Rev Food Sci Nutr; 2022; 62(4):957-979. PubMed ID: 33081493 [TBL] [Abstract][Full Text] [Related]
9. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway. Kim YS; Choi KC; Hwang KA Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
11. Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis. Pal M; Bhattacharya S; Kalyan G; Hazra S Exp Cell Res; 2018 Jul; 368(2):137-146. PubMed ID: 29674112 [TBL] [Abstract][Full Text] [Related]
13. A Hybrid Epithelial to Mesenchymal Transition in Ex Vivo Cutaneous Squamous Cell Carcinoma Tissues. Pulford CS; Uppalapati CK; Montgomery MR; Averitte RL; Hull EE; Leyva KJ Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012449 [TBL] [Abstract][Full Text] [Related]
14. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration. Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803 [TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer. Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090 [TBL] [Abstract][Full Text] [Related]
16. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors. Bozhkova DM; Poryazova-Markova EG Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662 [TBL] [Abstract][Full Text] [Related]
17. E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT. Sommariva M; Gagliano N Cells; 2020 Apr; 9(4):. PubMed ID: 32331358 [TBL] [Abstract][Full Text] [Related]
18. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. Giannelli G; Koudelkova P; Dituri F; Mikulits W J Hepatol; 2016 Oct; 65(4):798-808. PubMed ID: 27212245 [TBL] [Abstract][Full Text] [Related]
19. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639 [TBL] [Abstract][Full Text] [Related]
20. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Serrano-Gomez SJ; Maziveyi M; Alahari SK Mol Cancer; 2016 Feb; 15():18. PubMed ID: 26905733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]